4
Changes in Ownership
Vaxcyte, Inc. Filed Acc 0001649094-25-000004
SVP, GEN COUNSEL & CORP SEC sold 5,000 shares at an average $85.58 ($427,923)
- SVP, GEN COUNSEL & CORP SEC acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2025-01-06 | Option exercise 10b5-1 | +5,000 | $21.41 | $107,050 | 33,222 | D |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2025-01-06 | Sale 10b5-1 | −954 | $84.86 | $80,953 | 32,268 | D |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2025-01-06 | Sale 10b5-1 | −3,921 | $85.73 | $336,155 | 28,347 | D |
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2025-01-06 | Sale 10b5-1 | −125 | $86.52 | $10,815 | 28,222 | D |
| Derivatives | |||||||
| Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC | 2025-01-06 | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 154,497 | D | ||
| Open-market sales · 5,000 sh · avg $85.58 · $427,923 | |||||||
Loading xslF345X05/wk-form4_1736285608.xml…